Payer+Provider's Health System Review
October 27, 2022
New data from the CDC shows that U.S. life expectancy dropped by a total of 2.7 years between 2019 and 2021 to 76.1 years, the lowest number since 1996.
October 26, 2022
New classes of antibodies may be one of our best tools to overcome new immune evasive variants.
October 22, 2022
Cautious optimism about the use of a new anti-amyloid fibril antibody for the treatment of early-stage Alzheimer’s.
October 21, 2022
Monoclonal antibodies derived from macaque monkeys may be a new tool to fight against moderate to severe Covid-19.
Researchers have developed a “naked” self-amplifying RNA vaccine optimized for injection into the skin, rather than the muscle.
Improving air management can help fight Covid-19
Patients with drug-resistant multiple myeloma find early success with a new CAR T therapy, a recent study finds
October 17, 2022
In part 3 of my series on Alzheimer’s, I explore the different variants of APOE— the primary gene associated with Alzheimer’s disease.
October 15, 2022
The most common of these symptoms is pediatric dyspnea, otherwise known as shortness of breath or difficulty breathing.
Thanks to new techniques in regenerative medicine we are now closer to a future where your own cells can be used to restore the sense of vision.